ERBB2 and adenocarcinoma: It was shown that cytoplasmic estrogen receptor (ER)-α, cytoplasmic ER-β, and total progesterone receptor (PR) expression were higher in squamous cell carcinoma than in adenocarcinoma (AD), while HER2 expression was higher in adenocarcinoma than in squamous cell carcinoma (41).